ENERGY RAY-CURABLE INK COMPOSITION
    31.
    发明申请
    ENERGY RAY-CURABLE INK COMPOSITION 有权
    能量可固化油墨组合物

    公开(公告)号:US20090197988A1

    公开(公告)日:2009-08-06

    申请号:US12365710

    申请日:2009-02-04

    IPC分类号: C09D11/10

    CPC分类号: C09D11/30 C09D11/101

    摘要: An object of the present invention is to provide an energy ray-curable ink composition which is excellent in curability and adhesion, and is also excellent in storage stability.The present invention relates to an energy ray-curable ink composition comprising a coloring material; a polyfunctional monomer having three or more ethylenical double bonds in one molecule as a polymerizable compound; an α-aminoalkylphenone-based compound and a thioxanthone-based compound as photopolymerization initiators; and a hindered amine-based compound having a 2,2,6,6-tetramethylpiperidinyl group as an antigelling agent.

    摘要翻译: 本发明的目的是提供固化性和粘合性优异的能量射线固化性油墨组合物,并且保存稳定性也优异。 本发明涉及包含着色材料的能量射线固化型油墨组合物, 在一个分子中具有三个或更多个烯属双键的多官能单体作为可聚合化合物; α-氨基烷基苯酮类化合物和噻吨酮系化合物作为光聚合引发剂; 和具有2,2,6,6-四甲基哌啶基作为抗凝胶剂的受阻胺类化合物。

    Inclusion compounds of cyclodextrin with sulfur-containing compounds
    34.
    发明授权
    Inclusion compounds of cyclodextrin with sulfur-containing compounds 失效
    包含环糊精与含硫化合物的化合物

    公开(公告)号:US4482709A

    公开(公告)日:1984-11-13

    申请号:US432929

    申请日:1982-09-30

    摘要: This invention relates to inclusion compounds of cyclodextrin with the compounds of the general formula [I] and salts thereof, which show pharmacological effects (for example antihypertensive effect), ##STR1## wherein A is straight or branched lower alkylene;R.sup.1 is hydrogen or lower alkyl;R.sup.2 is hydrogen, lower alkyl, phenyl, phenyl-lower alkyl, hydroxyphenyl-lower alkyl, hydroxy-lower alkyl, amino-lower alkyl, guanidino-lower alkyl, imidazolyl-lower alkyl, indolyl-lower alkyl, mercapto-lower alkyl or lower alkylthio-lower alkyl;R.sup.1 or R.sup.2 may join to complete pyrrolidine ring or thiazolidine ring, and each ring may be substituted by phenyl or pyridyl, and phenyl may be resubstituted by hydroxy, lower alkoxy, halogen, nitro or sulfamoyl;R.sup.3 is hydrogen or ##STR2## said lower alkyl and lower alkoxy having 1 to 6 carbon atoms.

    摘要翻译: PCT No.PCT / JP82 / 00050 Sec。 371日期1982年9月30日 102(e)1982年9月30日PCT PCT 1982年2月24日PCT公布。 出版物WO82 / 02890 本发明涉及环糊精与通式[I]化合物及其盐的包合物,其显示药理作用(例如抗高血压作用),其中A是直的 或支链低级亚烷基; R1是氢或低级烷基; R2是氢,低级烷基,苯基,苯基 - 低级烷基,羟基苯基 - 低级烷基,羟基 - 低级烷基,氨基 - 低级烷基,胍基 - 低级烷基,咪唑基 - 低级烷基,吲哚基 - 低级烷基,巯基 - 低级烷基或低级 烷硫基 - 低级烷基; R1或R2可以连接成吡咯烷环或噻唑烷环,每个环可以被苯基或吡啶基取代,苯基可以被羟基,低级烷氧基,卤素,硝基或氨磺酰基取代; R3是氢或低级烷基和具有1至6个碳原子的低级烷氧基。

    Five-membered heterocyclic compounds
    35.
    发明授权
    Five-membered heterocyclic compounds 失效
    五元杂环化合物

    公开(公告)号:US4464371A

    公开(公告)日:1984-08-07

    申请号:US406241

    申请日:1982-07-27

    CPC分类号: C07D277/06

    摘要: This invention relates to the compound of the general formula [I], process for preparing the compound and antihypertensive agent containing the compound as a main ingredient. ##STR1## wherein R.sup.1 is hydrogen, hydroxy, lower alkyl or lower alkoxy;R.sup.2 is hydrogen, benzoyl or ##STR2## R.sup.3 is hydroxy, lower alkoxy, --NHOH or ##STR3## R.sup.4 is ##STR4## R.sup.5 is hydrogen or halogen; R.sup.6 and R.sup.7 each is hydrogen or lower alkyl;Z is straight or branched alkylene containing 1 to 3 carbon atoms;when R.sup.3 is hydroxy or lower alkoxy, R.sup.2 is ##STR5## and salts thereof, said lower alkyl and lower alkoxy groups contain 1 to 6 carbon atoms.

    摘要翻译: PCT No.PCT / JP81 / 00401 Sec。 371日期1982年7月27日 102(e)日期1982年7月27日PCT提交1981年12月22日PCT公布。 出版物WO82 / 02200 日本公开日1982年7月8日。本发明涉及通式[I]的化合物,该化合物和含有该化合物作为主要成分的抗高血压药的制备方法。 其中R 1是氢,羟基,低级烷基或低级烷氧基; R 2是氢,苯甲酰基或者R 3是羟基,低级烷氧基,-NHOH或R 4是R 5是氢或卤素; R6和R7各自为氢或低级烷基; Z是含有1至3个碳原子的直链或支链亚烷基; 当R 3为羟基或低级烷氧基时,R 2为其盐,所述低级烷基和低级烷氧基含有1至6个碳原子。